{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:46:42Z","timestamp":1790282802206,"version":"4.1.0"},"reference-count":30,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.2176\/jns-nmc.2023-0109","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T22:17:02Z","timestamp":1699654622000},"page":"315-320","source":"Crossref","is-referenced-by-count":1,"title":["Malignant Transformation and Leptomeningeal Melanomatosis in a Primary Meningeal Melanocytoma: A Case Report and Review of Literature"],"prefix":"10.2176","volume":"10","author":[{"given":"Kenta","family":"NAKASE","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"OKAMOTO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"NAKAGAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"TAKEDA","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"SAKATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yokohama City University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"NAKASE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Uramaru K, Sakata K, Shimohigoshi W, Kawasaki T, Manaka H: Primary meningeal melanocytoma located in the craniovertebral junction: a case report and literature review. <i>NMC Case Rep J<\/i> 8: 349-354, 2021","DOI":"10.2176\/nmccrj.cr.2020-0191"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yang C, Fang J, Li G, et al.: Spinal meningeal melanocytomas: clinical manifestations, radiological and pathological characteristics, and surgical outcomes. <i>J Neurooncol<\/i> 127: 279-286, 2016","DOI":"10.1007\/s11060-015-2006-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) De Tella OI, Agner C, Aguiar PH, Herculano MA, Prandini MN, Stavile JN: Aggressive management of orbital meningeal melanocytoma. <i>Acta Neurochir (Wien)<\/i> 145: 1121-1126, 2003","DOI":"10.1007\/s00701-003-0121-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Limas C, Tio FO: Meningeal melanocytoma ( &apos;melanotic Meningioma&apos;). Its melanocytic origin as revealed by electron microscopy. <i>Cancer<\/i> 30: 1286-1294, 1972","DOI":"10.1002\/1097-0142(197211)30:5<1286::AID-CNCR2820300522>3.0.CO;2-V"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hean V, Bouleftour W, Ramirez C, Forest F, Boutet C, Rivoirard R: Nivolumab as adjuvant treatment for a spinal melanocytoma: a case report. <i>Med (United States)<\/i> 100: e25862, 2021","DOI":"10.1097\/MD.0000000000025862"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Uozumi Y, Kawano T, Kawaguchi T, et al.: Malignant transformation of meningeal melanocytoma: A case report. <i>Brain Tumor Pathol<\/i> 20: 21-25, 2003","DOI":"10.1007\/BF02478943"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Roser F, Nakamura M, Brandis A, Hans V, Vorkapic P, Samii M: Transition from meningeal melanocytoma to primarycerebral melanoma. <i>J Neurosurg<\/i> 101: 528-531, 2004","DOI":"10.3171\/jns.2004.101.3.0528"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Wang F, Li X, Chen L, Pu X: Malignant transformation of spinal meningeal melanocytoma. Case report and review of the literature. <i>J Neurosurg Spine<\/i> 6: 451-454, 2008","DOI":"10.3171\/spi.2007.6.5.451"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Perrini P, Caniglia M, Pieroni M, Castagna M, Parenti GF: Malignant transformation of intramedullary melanocytoma: case report. <i>Neurosurgery<\/i> 3: 1-6, 2010","DOI":"10.1227\/01.NEU.0000372919.96651.34"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Wang F, Qiao G, Lou X, Song X, Chen W: Malignant transformation of intracranial meningeal melanocytoma. Case report and review of the literature. <i>Neuropathology<\/i> 31: 414-420, 2011","DOI":"10.1111\/j.1440-1789.2010.01160.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gempt J, Buchmann N, Grams AE, et al.: Black brain: transformation of a melanocytoma with diffusemelanocytosis into a primary cerebral melanoma. <i>J Neurooncol<\/i> 102: 323-328, 2011","DOI":"10.1007\/s11060-010-0311-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) K\u00fcsters-Vandevelde HVN, Kruse V, Van Maerken T, et al.: Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis. <i>Exp Mol Pathol<\/i> 102: 25-31, 2017","DOI":"10.1016\/j.yexmp.2016.12.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Deng SL, Wang YB, Wang DH, Zhan S, Jing Y, Guan Y: Malignant transformation and metastatic spread of dumbbell-shaped meningeal melanocytoma of the cervical spine: a case report and literature review. <i>Front Surg<\/i> 9: 1-8, 2022","DOI":"10.3389\/fsurg.2022.789256"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) San-Miguel T, Navarro L, Sanchez-Sendra B, et al.: Identification of a novel BRCA1 alteration in recurrent melanocytoma resulting in increased proliferation. <i>J Neuropathol Exp Neurol<\/i> 79: 1233-1238, 2020","DOI":"10.1093\/jnen\/nlaa089"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Prasad GL, Divya S: Intracranial meningeal melanocytomas: clinicoradiologic characteristics and outcomes. <i>World Neurosurg<\/i> 168: 298-308, 2022","DOI":"10.1016\/j.wneu.2022.08.051"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ricchizzi S, Gallus M, Stummer W, Holling M: How should we treat meningeal melanocytoma? A retrospective analysis of potential treatment strategies. <i>Cancers (Basel)<\/i> 14: 5851, 2022","DOI":"10.3390\/cancers14235851"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Doglietto F, Colosimo C, Lauriola L, et al.: Intracranial melanocytic meningeal tumours and melanosis oculi: case report and literature review. <i>BMC Cancer<\/i> 12: 2-7, 2012","DOI":"10.1186\/1471-2407-12-220"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bydon A, Gutierrez JA: Meningeal melanocytoma: an aggressive course for a benign tumor. <i>J Neurooncol<\/i> 64: 259-263, 2003","DOI":"10.1023\/A:1025628802228"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Palicelli A, Disanto MG, Panzarasa G, et al.: Orbital meningeal melanocytoma: histological, immunohistochemical and molecular characterization of a case and review of the literature. <i>Pathol Res Pract<\/i> 212: 946-953, 2016","DOI":"10.1016\/j.prp.2016.07.009"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Prabhu SS, Lynch PG, Keogh AJ, Parekh HC: Intracranial meningeal melanocytoma: a report of two cases and a review of the literature. <i>Surg Neurol<\/i> 40: 516-521, 1993","DOI":"10.1016\/0090-3019(93)90058-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lang-Orsini M, Wu J, Heilman CB, et al.: Primary meningeal melanoma masquerading as neurofibromatosis type 2: illustrative case. <i>J Neurosurg Case Lessons<\/i> 15: 2, 2021","DOI":"10.3171\/CASE21444"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) K\u00fcsters-Vandevelde HV, K\u00fcsters B, van Engen-van Grunsven AC, et al.: Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects. <i>Brain Pathol<\/i> 25: 209-226, 2015","DOI":"10.1111\/bpa.12241"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shoushtari AN, Kudchadkar RR, Panageas K, et al.: A randomized Phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma. <i>J Clin Oncol<\/i> 34: 9511-9511, 2016","DOI":"10.1200\/JCO.2016.34.15_suppl.9511"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Darman RB, Seiler M, Agrawal AA, et al.: Cancerassociated SF3B1 hotspot mutations induce Cryptic 30 splice site selection through use of a different branch point. <i>Cell Rep<\/i> 13: 1033-1045, 2015","DOI":"10.1016\/j.celrep.2015.09.053"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM: Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. <i>Nat Genet<\/i> 45: 133-135, 2013","DOI":"10.1038\/ng.2523"},{"key":"26","unstructured":"26) Malcovati L, Papaemmanuil E, Bowen DT, et al.: Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms. <i>Blood<\/i> 8; 118: 6239-6246, 2011"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Terai M, Shimada A, Chervoneva I, et al.: Prognostic values of G-protein mutations in metastatic uveal melanoma. <i>Cancers (Basel)<\/i> 13: 5749, 2021","DOI":"10.3390\/cancers13225749"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Griewank KG, Koelsche C, van de Nes JAP, et al.: Integratedgenomic classification of melanocytic tumors of the central nervoussystem using mutation analysis, copy number alterations, anddna methylation profiling. <i>Clin Cancer Res<\/i> 24: 4494-4504, 2018","DOI":"10.1158\/1078-0432.CCR-18-0763"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Leeksma AC, Derks IAM, Haidar Kasem M, et al.: he effect of SF3B1 mutation on the DNA damage response and nonsense-mediated. mRNA decay in cancer. <i>Front Oncol<\/i> 10: 609409, 2020","DOI":"10.3389\/fonc.2020.609409"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hamard PJ, Santiago GE, Liu F, et al.: Abstract 1137: PRMT5 inhibition regulates alternative splicing and DNA damage repair pathways in SF3B1 R625G expressing uveal melanoma cells. <i>Cancer Res<\/i> 81: 1137-1137, 2021","DOI":"10.1158\/1538-7445.AM2021-1137"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/10\/0\/10_2023-0109\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T05:14:34Z","timestamp":1699679674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/10\/0\/10_2023-0109\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":30,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2023-0109","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]},"article-number":"2023-0109"}}